<Entry>
<Accession>P02760</Accession>
        <ProteinName>Trypstatin</ProteinName>
        <GeneName>AMBP</GeneName>
        <OS_id>9606</OS_id>
        <ReferenceProteome>None</ReferenceProteome>
        <SubcellularLocation>
<Location>SL-0178</Location>
<Location>SL-0182</Location>
<Comments>[Alpha-1-microglobulin]: Secreted {ECO:0000269|PubMed:11877257, ECO:0000269|PubMed:32092412}. Endoplasmic reticulum {ECO:0000269|PubMed:22096585}. Cytoplasm, cytosol {ECO:0000269|PubMed:32092412}. Cell membrane {ECO:0000269|PubMed:22096585, ECO:0000269|PubMed:32092412}; Peripheral membrane protein {ECO:0000305|PubMed:22096585, ECO:0000305|PubMed:32092412}. Nucleus membrane {ECO:0000269|PubMed:22096585}; Peripheral membrane protein {ECO:0000305|PubMed:22096585}. Mitochondrion inner membrane {ECO:0000305|PubMed:23157686}; Peripheral membrane protein {ECO:0000305|PubMed:23157686}. Secreted, extracellular space, extracellular matrix {ECO:0000269|PubMed:22096585}. Note=The cellular uptake occurs via a non-endocytotic pathway and allows for localization to various membrane structures. A specific binding to plasma membrane suggests the presence of a cell receptor, yet to be identified. Directly binds collagen fibers type I. {ECO:0000269|PubMed:22096585}.</Comments>
</SubcellularLocation>
<CrossReferences>
<CrossReference>
<Database>UNIPROT</Database>
<ID>P02760</ID>
</CrossReference>
<CrossReference>
<Database>UNIPROT</Database>
<ID>P00977</ID>
</CrossReference>
<CrossReference>
<Database>UNIPROT</Database>
<ID>P02759</ID>
</CrossReference>
<CrossReference>
<Database>UNIPROT</Database>
<ID>P78491</ID>
</CrossReference>
<CrossReference>
<Database>UNIPROT</Database>
<ID>Q2TU33</ID>
</CrossReference>
<CrossReference>
<Database>UNIPROT</Database>
<ID>Q5TBD7</ID>
</CrossReference>
<CrossReference>
<Database>UNIPROT</Database>
<ID>Q9UC58</ID>
</CrossReference>
<CrossReference>
<Database>UNIPROT</Database>
<ID>Q9UDI8</ID>
</CrossReference>
<CrossReference>
<Database>PDB</Database>
<ID>1BIK</ID>
</CrossReference>
<CrossReference>
<Database>PDB</Database>
<ID>3QKG</ID>
</CrossReference>
<CrossReference>
<Database>PDB</Database>
<ID>4ES7</ID>
</CrossReference>
<CrossReference>
<Database>PDB</Database>
<ID>4U30</ID>
</CrossReference>
<CrossReference>
<Database>PDB</Database>
<ID>6EJ7</ID>
</CrossReference>
<CrossReference>
<Database>PDB</Database>
<ID>6EJ8</ID>
</CrossReference>
<CrossReference>
<Database>PDB</Database>
<ID>6EJ9</ID>
</CrossReference>
<CrossReference>
<Database>PDB</Database>
<ID>6EJA</ID>
</CrossReference>
<CrossReference>
<Database>PDB</Database>
<ID>6EJB</ID>
</CrossReference>
<CrossReference>
<Database>PDB</Database>
<ID>6EJC</ID>
</CrossReference>
<CrossReference>
<Database>PDB</Database>
<ID>6EJD</ID>
</CrossReference>
<CrossReference>
<Database>Pfam</Database>
<ID>PF00014</ID>
</CrossReference>
<CrossReference>
<Database>Pfam</Database>
<ID>PF00061</ID>
</CrossReference>
<CrossReference>
<Database>PROSITE</Database>
<ID>PS00280</ID>
</CrossReference>
<CrossReference>
<Database>PROSITE</Database>
<ID>PS50279</ID>
</CrossReference>
<CrossReference>
<Database>PROSITE</Database>
<ID>PS00213</ID>
</CrossReference>
<CrossReference>
<Database>OMIM</Database>
<ID>176870</ID>
</CrossReference>
<CrossReference>
<Database>DisGeNET</Database>
<ID>259</ID>
</CrossReference>
</CrossReferences>
<Function>[Alpha-1-microglobulin]: Antioxidant and tissue repair protein with reductase, heme-binding and radical-scavenging activities. Removes and protects against harmful oxidants and repairs macromolecules in intravascular and extravascular spaces and in intracellular compartments (PubMed:11877257, PubMed:15683711, PubMed:22096585, PubMed:23157686, PubMed:23642167, PubMed:25698971, PubMed:32823731, PubMed:32092412). Intravascularly, plays a regulatory role in red cell homeostasis by preventing heme- and reactive oxygen species-induced cell damage. Binds and degrades free heme to protect fetal and adult red blood cells from hemolysis (PubMed:11877257, PubMed:32092412). Reduces extracellular methemoglobin, a Fe3+ (ferric) form of hemoglobin that cannot bind oxygen, back to the Fe2+ (ferrous) form deoxyhemoglobin, which has oxygen-carrying potential (PubMed:15683711). Upon acute inflammation, inhibits oxidation of low- density lipoprotein particles by MPO and limits vascular damage (PubMed:25698971). Extravascularly, protects from oxidation products formed on extracellular matrix structures and cell membranes. Catalyzes the reduction of carbonyl groups on oxidized collagen fibers and preserves cellular and extracellular matrix ultrastructures (PubMed:23642167, PubMed:22096585). Importantly, counteracts the oxidative damage at blood-placenta interface, preventing leakage of free fetal hemoglobin into the maternal circulation (PubMed:21356557). Intracellularly, has a role in maintaining mitochondrial redox homeostasis. Bound to complex I of the respiratory chain of mitochondria, may scavenge free radicals and preserve mitochondrial ATP synthesis. Protects renal tubule epithelial cells from heme-induced oxidative damage to mitochondria (PubMed:23157686, PubMed:32823731). Reduces cytochrome c from Fe3+ (ferric) to the Fe2+ (ferrous) state through formation of superoxide anion radicals in the presence of ascorbate or NADH/NADPH electron donor cofactors, ascorbate being the preferred cofactor (PubMed:15683711). Has a chaperone role in facilitating the correct folding of bikunin in the endoplasmic reticulum compartment (By similarity). {ECO:0000250|UniProtKB:Q07456, ECO:0000269|PubMed:11877257, ECO:0000269|PubMed:15683711, ECO:0000269|PubMed:21356557, ECO:0000269|PubMed:22096585, ECO:0000269|PubMed:23157686, ECO:0000269|PubMed:23642167, ECO:0000269|PubMed:25698971, ECO:0000269|PubMed:32092412, ECO:0000269|PubMed:32823731}. [Inter-alpha-trypsin inhibitor light chain]: Kunitz-type serine protease inhibitor and structural component of extracellular matrix with a role in extracellular space remodeling and cell adhesion (PubMed:25301953, PubMed:20463016). Among others, has antiprotease activity toward kallikrein, a protease involved in airway inflammation; inhibits GZMK/granzyme, a granule-stored serine protease involved in NK and T cell cytotoxic responses; and inhibits PLG/plasmin, a protease required for activation of matrix metalloproteinases (PubMed:16873769, PubMed:10480954, PubMed:15917224). As part of I-alpha-I complex, provides for the heavy chains to be transferred from I-alpha-I complex to hyaluronan in the presence of TNFAIP6, in a dynamic process that releases free bikunin and remodels extracellular matrix proteoglycan structures. Free bikunin, but not its heavy chain-bound form, acts as potent protease inhibitor in airway secretions (PubMed:16873769). Part of hyaluronan-rich extracellular matrix that surrounds oocyte during cumulus oophorus expansion, an indispensable process for proper ovulation (By similarity). Also inhibits calcium oxalate crystallization (PubMed:7676539). {ECO:0000250|UniProtKB:Q07456, ECO:0000269|PubMed:10480954, ECO:0000269|PubMed:15917224, ECO:0000269|PubMed:16873769, ECO:0000269|PubMed:20463016, ECO:0000269|PubMed:25301953, ECO:0000269|PubMed:7676539}. [Trypstatin]: Kunitz-type serine protease inhibitor. Has high catalytic efficiency for F10/blood coagulation factor Xa and may act as an anticoagulant by inhibiting prothrombin activation. Inhibits trypsin and mast cell CMA1/chymase and tryptase proteases. {ECO:0000250|UniProtKB:Q64240}.</Function>
<Interactions>
<Interaction>
<Partner>P69616</Partner>
<IntAct>EBI-7810311</IntAct>
<Score>0.53</Score>
</Interaction>
<Interaction>
<Partner>P07858</Partner>
<IntAct>EBI-7970369</IntAct>
<Score>0.60</Score>
</Interaction>
<Interaction>
<Partner>Q92569</Partner>
<IntAct>EBI-2115171</IntAct>
<Score>0.00</Score>
</Interaction>
<Interaction>
<Partner>P62993</Partner>
<IntAct>EBI-2115716</IntAct>
<Score>0.00</Score>
</Interaction>
<Interaction>
<Partner>P42336</Partner>
<IntAct>EBI-2116612</IntAct>
<Score>0.00</Score>
</Interaction>
<Interaction>
<Partner>P10176</Partner>
<IntAct>EBI-3904736</IntAct>
<Score>0.37</Score>
</Interaction>
<Interaction>
<Partner>Q9Y4D1</Partner>
<IntAct>EBI-3908964</IntAct>
<Score>0.37</Score>
</Interaction>
<Interaction>
<Partner>P40763</Partner>
<IntAct>EBI-3926609</IntAct>
<Score>0.37</Score>
</Interaction>
<Interaction>
<Partner>Q99XU0</Partner>
<IntAct>EBI-8852714</IntAct>
<Score>0.35</Score>
</Interaction>
<Interaction>
<Partner>Q13643</Partner>
<IntAct>EBI-10193895</IntAct>
<Score>0.56</Score>
</Interaction>
<Interaction>
<Partner>P14335</Partner>
<IntAct>EBI-11422579</IntAct>
<Score>0.37</Score>
</Interaction>
<Interaction>
<Partner>Q99IB8</Partner>
<IntAct>EBI-11599534</IntAct>
<Score>0.35</Score>
</Interaction>
<Interaction>
<Partner>P05067</Partner>
<IntAct>EBI-16716791</IntAct>
<Score>0.40</Score>
</Interaction>
</Interactions>
<OntologyTerms>
<Ontology>GO:0072562</Ontology>
<Ontology>GO:0009986</Ontology>
<Ontology>GO:0062023</Ontology>
<Ontology>GO:0005829</Ontology>
<Ontology>GO:0005783</Ontology>
<Ontology>GO:0070062</Ontology>
<Ontology>GO:0005576</Ontology>
<Ontology>GO:0005615</Ontology>
<Ontology>GO:0031314</Ontology>
<Ontology>GO:0005743</Ontology>
<Ontology>GO:0031965</Ontology>
<Ontology>GO:0005886</Ontology>
<Ontology>GO:0016209</Ontology>
<Ontology>GO:0019855</Ontology>
<Ontology>GO:0046904</Ontology>
<Ontology>GO:0030246</Ontology>
<Ontology>GO:0035374</Ontology>
<Ontology>GO:0098633</Ontology>
<Ontology>GO:0020037</Ontology>
<Ontology>GO:0019862</Ontology>
<Ontology>GO:0016491</Ontology>
<Ontology>GO:0016653</Ontology>
<Ontology>GO:0042803</Ontology>
<Ontology>GO:0004867</Ontology>
<Ontology>GO:0007155</Ontology>
<Ontology>GO:0098869</Ontology>
<Ontology>GO:0034614</Ontology>
<Ontology>GO:1903606</Ontology>
<Ontology>GO:0007565</Ontology>
<Ontology>GO:0042167</Ontology>
<Ontology>GO:0020027</Ontology>
<Ontology>GO:0050777</Ontology>
<Ontology>GO:0046329</Ontology>
<Ontology>GO:0030163</Ontology>
</OntologyTerms>
<Topology>
        <Type>Peripheral</Type>
        <Source>UniProt</Source>
        <Annotation>Curator Inference {ECO:0000305|PubMed:23157686}</Annotation>
        </Topology>
<Sequence>MRSLGALLLLLSACLAVSAGPVPTPPDNIQVQENFNISRIYGKWYNLAIGSTCPWLKKIMDRMTVSTLVLGEGATEAEISMTSTRWRKGVCEETSGAYEKTDTDGKFLYHKSKWNITMESYVVHTNYDEYAIFLTKKFSRHHGPTITAKLYGRAPQLRETLLQDFRVVAQGVGIPEDSIFTMADRGECVPGEQEPEPILIPRVRRAVLPQEEEGSGGGQLVTEVTKKEDSCQLGYSAGPCMGMTSRYFYNGTSMACETFQYGGCMGNGNNFVTEKECLQTCRTVAACNLPIVRGPCRAFIQLWAFDAVKGKCVLFPYGGCQGNGNKFYSEKECREYCGVPGDGDEELLRFSN</Sequence>
        <SequenceLength>352</SequenceLength>
        </Entry>